Metalla Royalty & Streaming Ltd.

Fundamentals8.0
Price Action7.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Margin rebound
  • Strong cash
  • Low leverage

AI
AI Summary

6.0

MTA has shifted from a cash-rich optionality play to a real operating turnaround, but with the stock already pricing in a strong rerating, investors should treat it as an execution-and-capital-deployment story where sustained free cash flow improvement is needed to justify the premium valuation.

Turnaround
Valuation
Execution‍ക

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • Margin rebound
  • Strong cash
  • Low leverage

MTA showed a sharp quarterly turnaround with strong margins, solid cash generation, and a fortress-like balance sheet, but the stock still looks stretched given its loss history, accumulated deficit, and tiny revenue base.

liquidity
valuation

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Breakout momentum
  • Higher highs
  • Short-term extended

MTA has rallied strongly over the last month from the mid-$7s to $9.75, breaking out of consolidation, clearing $9.20, and remaining bullish despite being short-term extended.

Bullish
Breakout
Support Level: $9.07-$9.13, then $8.75
Resistance Level: $9.20

Rapid surge from the mid-$7s through the $7.3-$7.9 consolidation to $9.75, increasing short-term volatility risk

Sentiment & News

6.0

Key News Insights:

  • Record Q2 results
  • IDE892 expansion
  • Ongoing dose escalation

Metalla delivered record Q2 2026 results, while IDEAYA advanced IDE892 into Part 2 expansion with target exposures reached and ongoing combination testing.

Biotech
Earnings

Positive operating momentum at Metalla and continued early-stage clinical progress at IDEAYA may support investor sentiment around both names